A prospective comparative study to evaluate the effect of Myo-inositol plus diet vs diet alone in patients with gestational diabetes mellitus

Authors

  • B Swathi Bharat School of pharmacy, Mangalpally, Ibrahimpatnam, Hyderabad-501510, India.
  • A Deepthi Bharat School of pharmacy, Mangalpally, Ibrahimpatnam, Hyderabad-501510, India.
  • B Sravani Bharat School of pharmacy, Mangalpally, Ibrahimpatnam, Hyderabad-501510, India.
  • Rekha Department of obstetrics and gynaecology, Durgabai Deshmukh Hospital and Research Centre, Vidyanagar, Hyderabad, India.
  • S Namratha Bharat School of pharmacy, Mangalpally, Ibrahimpatnam, Hyderabad-501510, India.
  • R Sandhya Bharat School of pharmacy, Mangalpally, Ibrahimpatnam, Hyderabad-501510, India.

DOI:

https://doi.org/10.30574/gscbps.2021.14.3.0076

Keywords:

Biological and Pharmaceutical Sciences, Myoinositol, OGTT test, Diet, Insulin

Abstract

Aim: The aim of this study was to compare the effect of Myo-inositol plus diet and diet alone in patients with gestational diabetes mellitus.

Materials and methods: A Randomized Prospective study was carried out in Gestational Diabetes Mellitus patients to evaluate the efficacy of Myoinositol+diet vs Diet alone in the department of Gynaecology, Durgabhai Deshmukh Hospital, a 300 bedded multispecialty hospital from September 2018-April 2019.OGTT test was conducted to measure blood glucose levels.

Results: Among the total number of patients (60), Myoinositol + diet is given in 50% and diet is given in 50% of the patients. Among 30 patients on diet, 19 patients couldn’t control rising blood glucose levels and were prescribed insulin for reduction of blood glucose levels. Among 30 patients on myoinositol+ diet, 4 patients couldn’t control 1 hr blood glucose levels and were prescribed insulin to control blood glucose levels.

Conclusion: This study showed that Myoinositol + diet is effective than only diet with respect to decrease in blood glucose levels and safety among patients with Gestational Diabetes Mellitus. Therefore, we conclude that myoinositol + diet is safe and effective in reducing fasting and 2hr blood glucose levels.

Metrics

Metrics Loading ...

References

Celentano C, Matarrelli B et al.Myo-inositol supplementation to prevent gestational diabetes mellitus. CurrDiab Rep. 2016; 16(3):30.

Alberti K, Zimmet P. Definition, diagnosis and classification of diabetes mellitus. Part-1 diagnosis and classification of diabetes mellitus.World Health OrganisationReport. Diabetic medicine. 1998; 15(7):539-53.

Alwan N,Tuffnell D, West J. Treatments for gestational diabetes. Cochrane database of systematic reviews. 2009; 3.

Kim C, Newton KM, Knopp RH. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes care. 2002; 25:1862-8.

Catalano P, Thomas A et al. Increased fetal adiposity: a very sensitive marker of abnormal in utero development. Am J obstet gynecol. 2003; 189(6): 1698-704.

Crowther C, Hiller J et al. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med. 2005; 352:2477-86.

Landon MB, Spong CY et al. A multicentre, randomized trial of treatment for mild gestational diabetes. N Engl J Med. 2009; 361(14):1339-48.

Eman M, Alfadhil, MD, FRCP. Gestational diabetes mellitus. Saudi med J. 2015; 36(4):399-406.

Tineke J, Crawford, Caroline A Crowther et al.; Dietary supplementation with Myo-inositol in women during pregnancy for treating gestational diabetes mellitus. Cochrane database of systematic review. 2016.

Croze ML, Soulage CO. Potential role and therapeutic interests of myo-inositol in metabolic diseases. Biochimie. 2013; 95(10):1811-27.

Tineke J Crawford, Caroline A Crowther et al.; Dietary supplementation with Myo-inositol in women during pregnancy for treating gestational diabetes mellitus. Cochrane database of systematic review. 2016.

Downloads

Published

2021-03-30

How to Cite

B Swathi, A Deepthi, B Sravani, Rekha, S Namratha, & R Sandhya. (2021). A prospective comparative study to evaluate the effect of Myo-inositol plus diet vs diet alone in patients with gestational diabetes mellitus. GSC Biological and Pharmaceutical Sciences, 14(3), 197–201. https://doi.org/10.30574/gscbps.2021.14.3.0076

Issue

Section

Original Article